






Laboratory assessment of iron status and reticulocyte parameters
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Introduction: The soluble form of transferrin receptor (sTfR) has been pointed as a useful
parameter to assess the iron status and erythropoiesis activity. Immature reticulocytes present
high concentration of membrane transferrin receptor. We tested the correlation between sTfR
and reticulocyte parameters in iron deficiency anemia (IDA) and heterozygous β-thalassemia
(hetero β-thal) patients. Laboratory parameters related to iron status and reticulocytes were
studied in order to establish their clinical value to distinguish both anemias. Material and
Methods: Reticulocyte measurements were obtained using a semi-automated analyzer and
serum concentration of sTfR was determined by an immunoenzymatic technique. Forty-nine
IDA and 43 hetero β-thal patients were studied. Results: Reticulocyte count and sTfR values
were significantly higher in IDA than in hetero β-thal group, but the best parameter to
distinguish both anemias was sTfR index, obtained by the ratio sTfR/ferritin level. Transport
compartment was better evaluated by transferrin dosage than by transferrin iron binding
capacity (TIBC) determination. The association of serum iron with transferrin measurements
(transferrin index) improved the accuracy of the transferrin test. Discussion: The correlation
between highly immature reticulocytes and sTfR level was observed only in IDA group,
suggesting that cellular iron deprivation is the main responsible factor for up regulation of the
sTfR synthesis in immature red blood cells. High sTfR values in hetero β-thal patients reflect a
degree of ineffective erythropoiesis in this hemoglobinopathy. Conclusion: We concluded that
sTfR, ferritin and transferrin measurements are useful and precise parameters to discriminate






Introdução: A forma solúvel do receptor da transferrina (sTfR) tem sido indicada como um
parâmetro útil na avaliação do estado do ferro e da atividade eritropoiética. Reticulócitos imaturos
apresentam alta concentração dos receptores de transferrina na sua membrana. Estudamos a
correlação entre sTfR e parâmetros reticulocitários em pacientes com anemia ferropriva (AF) e com
β-talassemia heterozigótica (β-tal hetero). Os parâmetros laboratoriais relacionados ao estado do
ferro e reticulócitos foram estudados a fim de se estabelecer a utilidade clínica dos mesmos na
distinção entre os dois tipos de anemia. Material e métodos: As medidas reticulocitárias foram
obtidas usando-se um analisador hematológico semi-automático, e as concentrações de sTfR foram
determinadas por técnica imunoenzimática. Foram estudados 49 pacientes com AF e 43 com β-tal
hetero. Resultados: As contagens de reticulócitos e os valores de sTfR foram significativamente mais
elevados na AF do que na β-tal hetero, mas o melhor parâmetro para diferenciar  as duas anemias
foi o índice de sTfR, obtido pela razão sTfR/ferritina. O compartimento de transporte foi mais bem
avaliado pela dosagem de transferrina do que pela capacidade de ligação do ferro à transferrina
(TIBC). A associação do ferro sérico à medida de transferrina (índice de transferrina) melhorou a
acurácia do teste de transferrina. Discussão: A correlação entre reticulócitos imaturos e nível de sTfR
foi observada apenas no grupo com AF, sugerindo que a falta de ferro intracelular seja o principal
fator responsável pelo estímulo à síntese de sTfR nas células sangüíneas imaturas. Os valores
elevados de sTfR nos pacientes com β-tal hetero refletem um certo grau de eritropoiese ineficaz
nessa hemoglobinopatia. Conclusão: Concluímos que as medidas de sTfR, ferritina e transferrina são
parâmetros úteis e precisos para diferenciar AF de β-tal hetero.
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Laboratory assessment of iron status and reticulocyte parameters in differential diagnosis of iron deficiency anemia and heterozygous β-thalassemia Lima & Grotto
Introduction
New and reliable laboratory measurements of iron
status have been used for detecting and assessing different
stages of iron deficiency. Furthermore, there is a consensus
that iron status should be interpreted using a group of
parameters and not only one single test. It is also pertinent
to consider costs and time spent to achieve a correct
diagnosis.
Some authors have suggested the use of reticulocyte
parameters to distinguish iron deficiency anemia (IDA)
from heterozygous β-thalassemia (hetero β-thal) (26), both
presenting  hypochromia and microcytosis of erythrocytes
and both with a high incidence in Brazil (21). The clinical
value of the reticulocyte quantitation was renewed by the
automation of the reticulocyte count together with the
possibility of determining the immaturity of reticulocyte
population as erythropoiesis activity analysis (8). Yoldi et
al. (26) evaluated samples from hetero β-thal and IDA using
flux cytometry, and established that a value < 2% for highly
fluorescent reticulocytes (HFR) would be used to discri-
minate between these pathologies. Membrane reticulocyte
presents transferrin receptor and the receptor concen-
tration is higher in more immature cells. The soluble form
of transferrin receptor (sTfR) was first described by Kohgo
et al. (15) and corresponds to a truncated form lacking
the cytoplasmic and transmembrane domains of the intact
receptor (6). The sTfR determination has been pointed as
a useful parameter to assess the iron status and erythro-
poiesis activity (1).
The objective of this study was to test laboratory
parameters related to reticulocytes, iron metabolism,
including sTfR determination, in order to determine their
use to distinguish hetero β-thal from IDA.
Material and methods
Subjects
A group of adult patients (n = 92) with hypochromic
and microcytic anemia was studied. IDA (n = 49) was
defined as serum ferritin (SF) level below 30ng/ml for men
and 12ng/ml for women (minimum normal ferritin levels
in our laboratory). Patients with SF levels higher than the
above mentioned and Hb A2 level higher than 3.4 % were
considered as hetero β-thal (n = 43). Fifty-seven nonanemic
subjects were used as controls.
Methods
Hematological measurements including reticulocyte
parameters (absolute reticulocyte count and high
fluorescent reticulocytes – HFR) were obtained using a Cell
Dyn 3500 analyzer (Abbott – USA). Reticulocyte was
identified by a non-fluorescent method using New
methylene blue as dye. Fractions of reticulocyte maturity
were calculated depending on the absorption intensity and
they were classified as: mature, midmature and highly
immature reticulocytes fractions.
Hemoglobin A2 was quantified spectrophotometrically
after cellulose acetate electrophoresis (16).
Determination of iron status: determination of serum iron
(SI) and the transferrin iron binding capacity (TIBC) were
done with a Mira Plus Cobas analyzer (Roche – Switzerland)
using Unimate 5 Iron and Unimate 7 UIBC kits (Roche
Diagnostic Systems – Switzerland). SF was determined by a
chemiluminescence system (kit Immulite – Diagnostic
Products Co. – USA)
Transferrin concentration (TFR) was quantified by
nephelometric method (Beckman – Ireland). The serum
concentration of sTfR was measured by an immuno-
enzymatic technique (Quantikine – R&D Systems – USA).
Statistical analysis: In order to compare the variables
between groups, the Kruskal-Wallis test was employed. The
Spearman correlation coefficient test was used for assessing
the association between variables, with level of significance
set at < 0.05. The capacity of the tests to discriminate
between the groups was studied by means of ROC curves
that defined the optimal decision limit of each parameter
and the accuracy of each method. The protocol of this
study was approved by the Committee of Ethics of the
School of Medical Sciences, University of Campinas, São
Paulo, Brazil.
Results
The distribution of laboratory values among the
patients and control groups are shown in Table 1. Two
indicators, TI and sTfRI, were included, obtained by the
ratio SI/TRF and by the ratio sTfR/SF, respectively (2, 20).
Comparing the variables between groups, a significant
difference was observed between normal and hetero β-
thal, normal and IDA, and hetero β-thal and IDA in
reticulocyte indices and sTfR concentrations (p = 0.0001).
TFR, TI and sTfRI were significantly different between IDA
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                   Groups
Parameters Control (n = 57) Hetero β-thal (n = 43) IDA (n = 49)
Rtc* (x 106/l) 67.9 ± 17.6 (28.8-134.0) 160.19 ± 137.8 (64-808) 93.7 ± 52.43 (31.0-305.0)
HFR (%) 6.2 ± 2.9 (2.9-18.9) 7.33 ± 3.74 (6.6-23.6) 6.96 ± 3.55 (1.9-21.2)
SI (µg/dl) 96.7 ± 29.3 (42.0-149.0) 86.8 ± 29.7 (24.0-163.0) 26.6 ± 17.45 (2.0-76.0)
TIBC (µg/dl) 352.4 ± 58.5 (245.0-467.0) 402.9 ± 99.9 (264.0-689.0) 409.1 ± 105.8 (210.0-630.0)
TS (%) 28.0 ± 11.0 (12.0-60.0) 24.0 ± 12.0 (10.0-60.0) 8.0 ± 9.0 (1.0-6.0)
SF (ng/ml) 103.8 ± 72.4 (17.7-334.0) 142.24 ± 156.2 (24.0-682.0) 7.4 ± 4.75 (1.5-23.5)
TRF* (mg/dl) 249.8 ± 28.7 (202.0-317.0) 231.1 ± 55.7 (125.0-366.0) 337.5 ± 61.3 (111.0-427.0)
TI* 0.41 ± 0.11 (0.20-0.65) 0.39 ± 0.15 (0.18-0.76) 0.08 ± 0.05 (0.01-0.26)
sTfR* (nmol/l) 16.88 ± 3.1 (12.5-27) 27.1 ± 15.82 (15.0-91.0) 50.26 ± 21.4 (23.5-108.5)
sTfRI* 27.7 ± 23.60 (5.2-99.4) 46.51 ± 48.92 (3.0-279) 1287.5 ± 1329.2 (119.0-5812.0)
Rtc: reticulocyte count; HFR: high immature reticulocyte fraction; SI: serum iron; TIBC: transferrin iron binding capacity; TS: transferrin saturation; SF: serum ferritin; TRF:
serum transferrin; TI: transferrin index = SI/TRF; sTfR: soluble transferrin receptor; sTfRI: sTfR index = sTfR/SF. *p < 0.05.
Hematological and iron parameters in different groups of patients and control.
Values are means ± SD and rangeTable 1
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Variables Control Hetero β-thal IDA
HFR x sTfR r = 0.049 r = 0.007 r = 0.349
p = 0.795 p = 0.963 p = 0.025
sTfRI x SI r = - 0.081 r = 0.087 r = - 0.140
p = 0.670 p = 0.611 p = 0.381
TS x TI r = 0.904 r = 0.628 r = 0.675
p = 0.0001 p = 0.0001 p = 0.0001
TIBC x TRF r = 0.688 r = 0.169 r = 0.517
p = 0.0001 p = 0.322 p = 0.0005
sTfR x SF r = 0.178 r = 0.0117 r = - 0.384
p = 0.345 p = 0.945 p = 0.013
sTfR x Rtc r = 0.262 r = 0.2883 r = 0.170
p = 0.1615 p = 0.0881 p = 0.286
sTfR x Hb r = 0.121 r = - 0.4249 r = - 0.1117
p = 0.523 p = 0.0098 p = 0.4867
Hb: hemoglobin (g/dl).
Correlation between variables in patients with hetero β-thal, IDA and controlsTable 2
Groups
and hetero β-thal and also between IDA and control groups
(p = 0.0001).
The correlation between HFR and sTfR was modest
(r = 0.349), but significant (p = 0.025) only in IDA group.
Transferrin saturation (TS) and TI indices measure iron
transport compartment and the correlation coefficients were
positive in all groups (Table 2). However, TI was more accurate
than TS to distinguish IDA from hetero β-thal, with 100% of
specificity for TI (Table 3 and Figure 1). Two of 41 IDA patients
showed TI > 0.17: one of them showed TRF concentration
below normal limit and the other one presented a normal SI
concentration. The latter one was iron depleted (low ferritin
level), although SI concentration was normal. Comparing TIBC
and TRF accuracies, we could observe that TRF had a better
performance than TIBC to recognize IDA patients (Table 3).












































Three of them could be identified as IDA by TI value. The
other one presented TRF concentration below normal limit
and sTfRI compatible with IDA. We did not investigate if
the patient had some associated clinical condition that
could explain a decreasing synthesis or loss of TRF. Ten of
the 43 hetero β-thal patients presented TIBC values higher
than the superior normal limit. One of them showed results
compatible with iron deficiency, although ferritin level was
normal (SF = 27 mg/l). Transferrin saturation, sTfR and sTfRI
values (10%, 72nmol/l and 270, respectively) indicated an
iron depletion, but TRF concentration, contrary to expected,
showed normal values (212mg/dl). The second patient was
firstly classified as hetero β-thal, according to hematological
values, HbA2 and ferritin determinations. However, the film
examination revealed nucleated red blood cells, punctuate
basophilic, poikilocytes and cell fragments. In fact, clinical
features suggest that this individual is β-thalassemic
intermedia patient. Medical records reported a splenectomy
when the patient was 7 years old and repetitive transfusion
proceedings from 7 to 22 years old, due to anemia.
Nowadays the patient presents an associated chronic liver
disease. The high TIBC value (476mg/dl), low transferrin
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Parameter Accuracy Sensitivity Specificity Decision
(%) (%) (%) limit
Rtc 76.2 68.0 74.4 ≤ 93 x 106/l
HFR 54.1 82.0 30.2 ≤ 8.3%
TIBC 53.6 60.0 62.8 ≥ 401µg/dl
TS 94.2 84.0 95.3 ≤ 10%
TI 99.2 95.1 100 ≤ 0.17
TRF 90.1 87.8 88.9 ≥ 278mg/dl
sTfR 87.6 100 69.4 ≥ 23nmol/l
sTfRI 99.7 97.6 97.2 ≥ 140
Accuracy, sensitivity, specificity and cutoff values to distinguish IDA from hetero β-thal
(ROC curve results)Table 3
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saturation and serum iron determinations suggest an
associated iron deficiency anemia, a diagnosis which has
been reinforced by an elevated sTfR value (41nmol/l). The
other eight patients did not present additional laboratorial
results that could explain high TIBC values. sTfR
measurement showed an accuracy of 0.876 (Figure 2) and
this result was improved by the ratio sTfRI (accuracy =
0.997) (Figure 3). Only one IDA and one hetero β-thal
showed values out of limits, providing 97.6% sensitivity
and 97.2% specificity for sTfRI parameter.
 Discussion
Transferrin receptors are membrane glycoproteins
responsible for binding transferrin during the endocytosis
of iron. The density of surface transferrin receptor is
proportional to the iron requirement of the cell. Then, the
transferrin is abundant in cells of organs with the highest
iron requirements, such as the erythron marrow and the
placenta. After internalization by endocytosis, the
endosome containing the transferrin-receptor complex
becomes acidified and iron loses its affinity for transferrin.
Receptor and transferrin return to the cell surface, where
the transferrin is released while the iron is transported to
the cytosol (7). The initial study about circulating transferrin
receptor was reported by Kohgo et al. (15). They demons-
trated that the concentration of this protein was
significantly elevated in enhanced erythropoiesis and iron
deficiency. The clinical use of the sTfR has been reported
in several situations, especially to distinguishing iron
deficiency from the hypoproliferative anemia that is
associated with chronic diseases (10). The serum receptor
increases with the severity of the iron deficiency anemia,
but not in chronic diseases. In addition, sTfR provides an
assessing of erythropoiesis status, because an increase in
the sTfR concentration is proportional to the expansion of
the erythroid marrow (13). In hemolytic anemias with
efficient erythropoiesis there is a close parallel rise in sTfR
and absolute reticulocyte count (7). On the other hand,
in disorders in which there is an ineffective erythropoiesis,
such as myelodysplasia, an increase in sTfR is observed,
whereas discret reticulocyte count occurs (3). Patients with
hetero β-thal have increased erythroid marrow activity,
although they present various degrees of an ineffective
erythropoiesis (4).
The association of the sTfR and the serum ferritin by
the sTfR/ferritin index has been indicated as a helpful
parameter to identify patients with iron deficiency and to
distinguish those with iron deficiency from hetero β-thal












































Figure 3 –  sTFRI index in IDA and hetero β-thal. The discrimination limit is set at 140.0











Spec.: 97.2IDA Hetero β thal
hetero β-thal associated to IDA and observed that sTfR
was significantly higher in hetero β-thal than in normal
controls, but significantly lower than in IDA. sTfR was not
useful in diagnosing associated IDA in hetero β-thal
patients.
In our study we tested parameters related to sTfR,
transferrin and reticulocyte counts in patients with IDA
and hetero β-thal. Reticulocytes are good indicators of
erythropoiesis activity. Automated methods using flow
cytometry and RNA dyes resurrected the confidence in
reticulocyte counts and introduced new approaches
concerning bone marrow response by the quantification
of reticulocyte maturity (19). Thus, immature reticulocyte
fraction has been reported as an early predictor of the
regenerative activity of bone marrow after bone marrow
transplantation (8, 12).
Yoldi et al. (26) described high fluorescent reticulocytes
as a good discriminant between hetero β-thal and IDA,
since the value in IDA is higher than in hetero β-thal. Such
difference has not been found in our study. An explanation
for that fact could be that the used methodology has not
included fluorescence to identify reticulocyte maturity.
However, we carried out a similar study using flow
cytometry and thiazole orange as dye and the results did
not change (HFR mean = 5.11 ± 4.47 to hetero β-thal and
HFR mean= 4.39 ± 4.55 to IDA, p > 0.05 – data not
published). It has been reported that reticulocytes in iron
deficient conditions may contain increased amounts of
transferrin receptor (18). Then, a positive correlation
between sTfR and HFR was expected. We observed a
modest but significant correlation between these
parameters in IDA, but not in hetero β-thal. Iron deficiency
causes an increase in the rate of transferrin receptor
production, due to both increased synthesis and increased
stability of transferrin receptor mRNA (17). Iron deficient
rats showed receptor density 74% over the normal rats in
function of an increasing in erythroid cells population and
an increase in transferrin receptor on the individual cell
(14). We tested the diagnostic use of sTfR for IDA and we
could determine a value where the test presents sensitivity
of 100% and specificity of 69.4% in distinguishing IDA
from hetero β-thal. The specificity increased to 97.2%
when sTfR value was combined with ferritin value,
confirming the results reported by Cermak (5). sTfR and
sTfRI detected IDA patients that could not be identified
by other laboratory parameters as TIBC, TS or TFR rates,
demonstrating the value of the sTfR measurement for
identifying functional iron deficiency. We observed a
negative correlation between sTfR and ferritin levels. Skikne
et al. (20) determined the sTfR changes during the
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evolution of iron deficiency in a phlebotomy program. They
demonstrated that there was a progressive elevation in
sTfR when serum ferritin fell below the normal range.
Before this stage there was no significant change in sTfR
levels. All of our patients had serum ferritin below the
normal range and due to this fact we could observe an
inverse correlation between sTfR and ferritin. In the
phlebotomy study the mean sTfR/ferritin ratio was 100 at
baseline stage and a ratio of 500 identified the point at
which iron stores were fully exhausted. Our minimum sTfR/
ferritin ratio value was 110.0. Up to 140.0 hetero β-thal
patients could be identified.
Plasma iron transport is made by transferrin, a
monomeric glycoprotein that binds two atoms of Fe3+ with
high affinity (23). The TIBC is a measurement of transferrin
concentration and was described by Ramsay forty years
ago. Despite TIBC being indispensable for determining iron
status, technical problems found by Bill Ramsay have not
been solved until now (9, 24). An alternative approach
would be measuring transferrin directly by immunological
assay. In our study, the nephelometry was used to measure
the concentration of transferrin, which showed to be a
more accurate method than TIBC. It  also has the
advantages of requiring a small sample and being
nonsusceptible to iron contamination (22). We could
notice the apparent limitation of TIBC estimation when
some of hetero β-thal patients showed high TIBC values,
although transferrin determination was normal. Probably
a spuriously high value was due to a non-transferrin iron
measurement (25).
We conclude that the interpretation of iron status is
based on a group of laboratory findings and, according to
our results, the association of sTfR and ferritin measu-
rements is more precise to distinguish hetero β-thal from
IDA. However, in a screening survey where it is pertinent
to consider costs, transferrin evaluation may be adopted,
since it showed a good performance to discriminate both
microcytic hypochromic anemias.
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